Chronic Myeloid Leukemia: Managing Patients After Failure of TKI Therapy

In this interactive presentation with downloadable slides, Elias Jabbour, MD, provides expert recommendations for treating patients with chronic myeloid leukemia who progress after treatment with 2 TKIs.
Elias Jabbour, MD


Elias Jabbour, MD, provides an overview of state-of-the-art postprogression treatment of CML after 2 previous TKIs.

Elias Jabbour, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: October 27, 2016 Expiration: October 26, 2017

In this downloadable slideset from the CML Clinical Focus program, Elias Jabbour, MD, provides expert perspective on optimizing treatment choices for patients with chronic myeloid leukemia after failure of 2 or more TKIs.

Released: October 28, 2016
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

This activity is supported by an educational grant from
Teva Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?